Investors on Fed Watch
Health Care: Health Services
Navidea Biopharmaceuticals Inc (NAVB: AMEX)
$2.66 -0.03 | -1.12%
06/18/13 - 04:03 PM ET
Latest Dividend:0.00
Latest Dividend Yield:0.00%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:n/a
Price Earnings Comparisons:
| NAVB | Sector Avg. | S&P 500 |
|---|---|---|
| n/a | 0.00 | 17.70 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| -12.37 | -10.63 | 0.00 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | -86.80 | -0.99 | -0.79 |
| Net Income | -100.00 | -0.23 | 0.00 |
| EPS | -100.00 | -0.46 | 0.00 |
Earnings for NAVB:
| EBITDA | -27.00 |
| REVENUE | 78.74K |
Average Earnings Estimates
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $-0.06 | $-0.05 | $-0.24 | $-0.11 |
| Number of Analysts | 1 | 1 | 3 | 2 |
| High Estimate | $-0.06 | $-0.05 | $-0.21 | $0.01 |
| Low Estimate | $-0.06 | $-0.05 | $-0.27 | $-0.23 |
| Prior Year | $-0.06 | $-0.09 | $-0.29 | $-0.24 |
| Growth Rate (Year over Year) | 0.00% | 44.44% | 17.24% | 54.17% |
Portfolios with NAVB
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- UserMy stocks
- ContributorDrugs Facing FDA Approval i...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- Userjennydog
- UserRogers BioMed
Latest NAVB Headlines from TheStreet
- 6 Stocks Under $10 Spiking Higher 04.04.13 | 03:04 pm
- Biotech Stock Mailbag: Delcath, Navidea, Affymax, Ziopharm 03.15.13 | 06:03 am
- Best And Worst FDA Drug Approval Stocks of 2013 03.12.13 | 08:03 am
- Play TheStreet's FDA Drug Approval Contest 03.05.13 | 12:03 pm
- Biotech Stock Mailbag: Celsion, Navidea, AP Pharma, Sarepta 02.01.13 | 07:02 am
- 5 Biotech Stocks Under $10 Moving Higher 01.30.13 | 08:01 am
- The Twitterverse's Biotech Stock Picks for 2013 01.02.13 | 08:01 am
- 13 Biotech Stock Predictions for 2013 01.02.13 | 06:01 am
- 2013 FDA Drug Approval Decision Calendar 12.19.12 | 09:12 am
- MAP Pharma's Awkward FDA Silence 11.14.12 | 09:11 am
Press Releases for NAVB
- Navidea Biopharmaceuticals Announces Enrollment Of First Subject In Phase 2b Trial Of NAV4694 In Subjects With Mild Cognitive Impairment (MCI) - Business Wire 03.27.13 | 09:03 am
- Results Of Lymphoseek® Phase 3 Clinical Trials In Breast Cancer Published In Annals Of Surgical Oncology - Business Wire 03.21.13 | 09:03 am
- Navidea Biopharmaceuticals To Hold Conference Call To Discuss Lymphoseek FDA Approval - Business Wire 03.13.13 | 02:03 pm
- FDA Approves Navidea’s Lymphoseek® (technetium Tc 99m Tilmanocept) Injection For Use In Lymphatic Mapping - Business Wire 03.13.13 | 01:03 pm
- Navidea Announces Fourth Quarter And Full-Year 2012 Results - Business Wire 03.06.13 | 04:03 pm
- Navidea Biopharmaceuticals To Announce Fourth-Quarter And Full-Year 2012 Financial Results On Wednesday, March 6, 2013 - Business Wire 03.04.13 | 02:03 pm
- Navidea Biopharmaceuticals To Present At The Cowen & Company 33rd Annual Health Care Conference - Business Wire 02.28.13 | 09:02 am
- Navidea Biopharmaceuticals To Present At The Citi 2013 Global Healthcare Conference - Business Wire 02.19.13 | 08:02 am
- Navidea Biopharmaceuticals Announces The Presentation Of Lymphoseek® Data At Upcoming Scientific Meetings - Business Wire 02.07.13 | 08:02 am
- Navidea Biopharmaceuticals To Present At The 15th Annual BIO CEO & Investor Conference - Business Wire 02.06.13 | 10:02 am
Partner Headlines for NAVB
- A Likely Turnaround And Short Squeeze For Navidea Shares - Seeking Alpha 03.18.13 | 09:03 am
- Quality Investors Knock On Navidea's Door; Validates Lymphoseek Potential - Seeking Alpha 01.31.13 | 09:01 am
- Navidea's Catalyst Will Pay Off - Seeking Alpha 01.16.13 | 09:01 am
- Testing, Testing: Analyst Kevin DeGeeter On 5 Good Bets In Cancer Diagnostics - Seeking Alpha 11.30.12 | 09:11 am
- Navidea: Interesting Biotech Story Gets Even More Dramatic - Seeking Alpha 10.02.12 | 09:10 am
- Morning Market Losers - Benzinga 09.11.12 | 09:09 am
- 4 Highly Liquid Small Cap Healthcare Stocks Set For Growth - Seeking Alpha 09.04.12 | 09:09 am
